Text Size
32 studies found for:    mononucleosis

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
mononucleosis
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection
Condition: Infectious Mononucleosis
Interventions: Drug: Valomaciclovir;   Drug: placebo
2 Completed Controlled Trial of Valacyclovir in Infectious Mononucleosis
Condition: Infectious Mononucleosis
Intervention: Drug: valacyclovir
3 Completed Acupuncture for Infectious Mononucleosis Trial
Condition: Infectious Mononucleosis
Interventions: Procedure: traditional Chinese acupuncture;   Other: standard medical care
4 Completed Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).
Condition: Epstein Barr Virus (EBV) Infection
Intervention: Biological: EBV vaccine (268664)
5 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
6 Completed Genetic Studies of X-linked Lymphoproliferative Disease
Conditions: X-Linked Lymphoproliferative Disease;   Lymphoproliferative Disease;   Genetic Diseases, X-Linked
Intervention:
7 Recruiting Specific Cytotoxic T-Lymphocytes, EBV-positive Lymphoma, GRALE
Conditions: Hodgkin's Disease;   Non-Hodgkin's Lymphoma;   Lymphoproliferative Disease;   Lymphoma
Interventions: Biological: LMP, BARF1 & EBNA1 specific CTLs: A;   Biological: LMP, BARF1 & EBNA1 specific CTLs : B
8 Completed Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus
Conditions: Epstein Barr Virus Infection;   Healthy
Intervention:
9 Recruiting Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
Conditions: Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Hodgkin Disease
Interventions: Biological: Antigen Escalation Stage;   Biological: Dose escalation study of T cells
10 Recruiting ARMS - Rapidly Generated Multivirus-Specific CTLs for the Prophylaxis And Treatment of EBV, CMV, Adenovirus, HHV6, and BK Virus
Condition: Viral Infection
Intervention: Biological: Multi-virus-specific cytotoxic T lymphocytes
11 Active, not recruiting Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma
Condition: Indolent Non-Hodgkin's Lymphoma
Intervention:
12 Recruiting A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Conditions: Congenital Cytomegalovirus Infection;   Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
13 Recruiting HIV Indicator Diseases Across Europe Study
Condition: HIV
Intervention:
14 Terminated Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
Conditions: Hodgkin Disease;   Non-Hodgkins Lymphoma
Intervention: Drug: Infusion of EBV Specific Cytotoxic T-Lymphocytes
15 Active, not recruiting Administration of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, ANGEL
Conditions: Epstein-Barr Virus-Related Hodgkin Lymphoma;   Epstein-Barr Virus-Related Non-Hodgkin Lymphoma;   EBV Positive Plasma Cell Neoplasm
Intervention: Genetic: Injection of EBV Specific CTLs
16 Completed T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
Condition: Head and Neck Cancer
Intervention: Biological: autologous EBV specific CTLs
17 Terminated Vaccination With Tetanus and KLH to Assess Immune Responses.
Condition: Cancer
Interventions: Biological: Intracel KLH Vaccine;   Biological: Biosyn KLH;   Drug: Montanide ISA51;   Biological: Tetanus toxoid
18 Terminated Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma
Conditions: Hodgkins Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Genetic: LMP1 SPECIFIC CYTOTOXIC T-LYMPHOCYTES;   Genetic: LMP2-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
19 Recruiting Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
Conditions: Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Lymphoproliferative Disorder;   Nasopharyngeal Carcinoma;   Leiomyosarcoma;   Severe Chronic Active EBV (SCAEBV)
Intervention: Biological: LMP specific T cells
20 Recruiting Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel;   Drug: Carboplatin;   Drug: Dexamethasone;   Biological: EBV-specific cytotoxic T lymphocytes
To Top

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
† Indicates status has not been verified in more than two years